U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07081958) titled 'A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity' on July 22.
Brief Summary: This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for chronic weight management in adult participants with obesity or overweight with at least one weight-related comorbidity, but without diabetes mellitus.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Obesity or Overweight
Intervention:
DRUG: RO7795081
RO77950...